VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $669,000 | -39.1% | 47,987 | -24.8% | 0.03% | -40.0% |
Q3 2019 | $1,098,000 | +49.4% | 63,787 | +136.4% | 0.06% | +31.0% |
Q2 2019 | $735,000 | +246.7% | 26,987 | +143.4% | 0.04% | +223.1% |
Q1 2019 | $212,000 | -41.3% | 11,087 | -40.0% | 0.01% | -13.3% |
Q2 2018 | $361,000 | -32.0% | 18,476 | -34.7% | 0.02% | -28.6% |
Q1 2018 | $531,000 | – | 28,276 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |